[ 29 ], which was a post hoc analysis from the EPHESUS trial, a reduction in all-cause mortality was observed in the eplerenone group that did not reach statistical significance.
← all excerpts
Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis.
1
—
—